CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has announced a key leadership transition as founder and Chief Medical Officer Dr. Rebecca Taub steps into the role of Senior Scientific and Medical Advisor while continuing her position on the company’s Board of Directors. Succeeding her, Dr. David Soergel will assume the role of Executive Vice President and Chief Medical Officer, effective April 21, 2025.
Dr. Taub, a pioneer in biopharma with a distinguished career spanning academic and industrial achievements, was instrumental in Madrigal’s success, including leading the development of the first FDA-approved treatment for MASH, Rezdiffra™ (resmetirom). “Becky’s groundbreaking efforts have been a driving force behind Madrigal’s advancements,” said CEO Bill Sibold. “Her contributions have transformed the landscape for patients with no prior treatment options, and we are fortunate to retain her expertise as she transitions into her advisory role.”
Dr. David Soergel brings over two decades of leadership in drug development, most recently serving as Executive Vice President and Global Head of Cardiovascular, Renal, and Metabolism Development at Novartis. His experience includes advancing therapies such as Entresto and Leqvio while spearheading major acquisitions. “Dave’s proven track record across multiple therapeutic areas aligns perfectly with our vision to broaden Madrigal’s pipeline,” Sibold added.
Reflecting on her 14 years at Madrigal, Dr. Taub expressed gratitude to her colleagues and the MASH community. “From a small R&D team in Conshohocken to a commercial-stage company with over 500 employees globally, Madrigal’s growth has been extraordinary,” she said.
Dr. Soergel expressed enthusiasm about joining Madrigal’s innovative team. “It’s an honor to build upon the strong foundation laid by Becky and contribute to a company at the forefront of MASH research,” he said.
With two outcome studies for Rezdiffra underway and plans for pipeline expansion, Madrigal Pharmaceuticals is poised to solidify its leadership and continue driving advances in therapy development.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.